AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Details continue to emerge, but multiple sources confirm that a Swedish teenager bled to death after taking RU486 last summer. In 1992 Sweden put RU486 on the market, one of the first countries in the world to approve its sale.
On March 12, 2004, Agence France-Presse (AFP) reported that the girl was in her seventh week of pregnancy when she sought an abortion at her local hospital in western Sweden. She was given RU486 (sold under the name Mifegyne in Europe), and returned home after a period of observation with instructions to call doctors if her bleeding became excessive.
According to AFP, a nurse attempting to contact her at home two days later was unsuccessful. Six days later she was found dead in her home. AFP reported that "Loss of blood from the abortion medication was cited as the official cause of death."
The case was reported to Swedish authorities, who ruled that doctors had given an appropriate dosage and followed proper procedure.
Other sources provide the name of the victim, her home town, and the date of her death. The Swedish daily Expressen of March 13, 2004, identified the girl as 16-year-old Rebecca Tell Berg of Uddevalla. The paper indicated she died June 3, 2003.
Unlike the AFP, which quotes only government agents (and appears to have mistakenly reported the young woman's age as 18), the Expressen spoke with Rebecca's mother, Catharina Tell. It offered a more complete account of the girl's last days.
Catharina Tell told the Expressen that Rebecca "didn't want to have a chemical abortion," but did so because "the doctor told her that it was much better than having a suction abortion."